170 related articles for article (PubMed ID: 24247359)
1. MiR-124 is related to podocytic adhesive capacity damage in STZ-induced uninephrectomized diabetic rats.
Li D; Lu Z; Jia J; Zheng Z; Lin S
Kidney Blood Press Res; 2013; 37(4-5):422-31. PubMed ID: 24247359
[TBL] [Abstract][Full Text] [Related]
2. Curcumin ameliorates Podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression.
Li D; Lu Z; Jia J; Zheng Z; Lin S
Kidney Blood Press Res; 2013; 38(1):61-71. PubMed ID: 24556741
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone ameliorates podocytic adhesive capacity via restoring integrin alpha 3 expression in streptozotocin-induced diabetic rats.
Lin S; Li D; Jia J; Zheng Z; Jia Z; Shang W
J Renin Angiotensin Aldosterone Syst; 2010 Sep; 11(3):149-57. PubMed ID: 20525748
[TBL] [Abstract][Full Text] [Related]
4. Changes in microRNAs associated with podocytic adhesion damage under mechanical stress.
Li D; Lu Z; Jia J; Zheng Z; Lin S
J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):97-102. PubMed ID: 23087255
[TBL] [Abstract][Full Text] [Related]
5. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
7. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
8. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule].
Sun W; Li CQ; Chen JH; Shao JD; Zhou D; Zhang L; Gao K
Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):81-90. PubMed ID: 23596882
[TBL] [Abstract][Full Text] [Related]
9. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
Chen LP; Zhou QL; Peng WS; Wu XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
[TBL] [Abstract][Full Text] [Related]
10. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
12. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
13. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
Yao T; Zha D; Gao P; Shui H; Wu X
J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
[TBL] [Abstract][Full Text] [Related]
14. Exosomal microRNA-16-5p from human urine-derived stem cells ameliorates diabetic nephropathy through protection of podocyte.
Duan YR; Chen BP; Chen F; Yang SX; Zhu CY; Ma YL; Li Y; Shi J
J Cell Mol Med; 2021 Dec; 25(23):10798-10813. PubMed ID: 31568645
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes.
Marotta F; Harada M; Dallah ED; Yadav H; Solimene U; Di Lembo S; Minelli E; Jain S; Chui DH
J Biol Regul Homeost Agents; 2010; 24(1):41-9. PubMed ID: 20385070
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
[TBL] [Abstract][Full Text] [Related]
17. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
[TBL] [Abstract][Full Text] [Related]
18. miR-218 regulates diabetic nephropathy via targeting IKK-β and modulating NK-κB-mediated inflammation.
Li M; Guo Q; Cai H; Wang H; Ma Z; Zhang X
J Cell Physiol; 2020 Apr; 235(4):3362-3371. PubMed ID: 31549412
[TBL] [Abstract][Full Text] [Related]
19. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
[TBL] [Abstract][Full Text] [Related]
20. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
